VERU (VERU) grants Director 7,000 options; vesting through 2028
Rhea-AI Filing Summary
Michael L. Rankowitz, a director of VERU Inc. (VERU), reported an acquisition of equity-linked compensation on 10/01/2025. The filing records the grant of 7,000 common stock options with an exercise price of $3.89, exercisable beginning 10/01/2026 and expiring 10/01/2035.
The options vest in three equal installments, with one-third vesting on each of 10/01/2026, 10/01/2027, and 10/01/2028. After the reported transaction the filing shows beneficial ownership of 7,000 shares/options held directly. The Form 4 was signed via power of attorney by Phil R. Greenberg on 10/03/2025.
Positive
- 7,000 options granted to a director, indicating board alignment with shareholder interests
- Options vest in thirds on 10/01/2026, 10/01/2027, and 10/01/2028, promoting multi-year retention
- 10‑year exercise window (expiring 10/01/2035) gives extended time for potential exercise
Negative
- None.
Insights
Director received time‑vested options aligning incentives with multi‑year performance.
The grant of 7,000 options to Director Michael L. Rankowitz vests in thirds over three years, which is a common design to retain board-level talent and align long‑term incentives with shareholder value.
The exercise price of $3.89 and the 10‑year term (expiring 10/01/2035) set the window for potential future share purchases; the filing shows these are held directly, indicating no indirect control layer disclosed.
Vesting schedule delays full economic benefit until 2028, pacing dilution.
One‑third vesting on each of 10/01/2026, 10/01/2027, and 10/01/2028 staggers potential exercise and any resulting dilution over three years rather than immediately.
The option exercise price is explicitly $3.89 and the underlying amount is 7,000 common shares; the filing does not disclose the grant’s accounting treatment or total outstanding share count, so precise dilution impact cannot be calculated from this Form 4 alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Option | 7,000 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
Who filed the Form 4 for VERU (VERU)?
What security and amount were reported in the VERU Form 4?
What is the exercise price and term of the options reported for VERU?
How do the options granted to the VERU director vest?
Does the Form 4 disclose the reporting person’s ownership after the transaction?